Infectious Disease Molecular Diagnostics Market Size, Share | Industry Report 2025

The global infectious disease molecular diagnostics market was valued at $ 780 Million in 2017 and is forecast to grow at a modest 10.5 % CAGR between 2018 and 2025, culminating in 2025 global sales of $ 1,799 Million.

Causal organism for infectious diseases could be bacteria, viruses, parasites or fungi and can be spread, directly or indirectly, from one person to another. Molecular diagnostic is showing promise in the identification of microorganisms as well as evaluation of virulence factors and antibiotic resistance determinants. Molecular infectious diseases diagnosis is moving towards high-throughput, simple, array-type technologies that provide a wealth of data on types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. Molecular diagnostic helping infectious diseases to be more accurately and effectively treated.

GBS specific gene could be detected from vaginal swab using real-time PCR assay to show the presence of normal flora (Lactobacillus sp.). Else to detect all potential bacteria in a blood sample, a broad-range PCR assay with post amplification analysis using gene sequencing. Global infectious molecular diagnostic market is expected to grow at a faster rate than expected due to rising demand from physicians, failure rate of conventional diagnosis, better and early detection, reducing cost of molecular diagnostic, improvement reimbursement coverage, technological. Moreover, high unmet needs across the developing and emerging nations is also expected to boost the molecular diagnostics over the next few years.

Microbial phenotypic such as protein, bacteriophage, and chromatographic profiles, biotyping and susceptibility testing, are used for identification and differentiation. As per CDC, 2,700 new cases of Hepatitis A in U.S. around 2011 and 19,000 new cases of hepatitis B. According to the National Institute of Allergy and Infectious Diseases, 50,000 new cases of HIV infections occur annually in the U.S., and nearly 33 million people are infected with HIV in the world. Even incidence of Human papillomavirus (HPV), Chlamydia, Gonorrhea, HIV and Syphilis (primary and secondary) is in rise.

North America accounted for over 46% revenue share in 2016. The key reasons attributed for the high share include the high prevalence of stomach and GI cancers, strong reimbursement framework, highly skilled medical professionals, technological advancements and government support for R&D and innovation in medical devices sector. Moreover, the presence of high-end hospital and POC and high emphasis on preventive screening is expected to boost the usage rates over the forecast period.

Asia Pacific is expected to register the maximum CAGR of 7.5% through 2017 to 2025. The rapid increase in a number of cancer cases, growing healthcare expenditure and skill training, and improvement in reimbursement scenario are expected to favor the high market growth in the region.

Click the link below to view the report description:
www.ameriresearch.com/product/infectious-disease-molecular-diagnostics-market/

Key findings from the study: -
• Molecular diagnostic helping infectious diseases to be more accurately and effectively treated.
• As per CDC, 2,700 new cases of Hepatitis A in U.S. around 2011 and 19,000 new cases of hepatitis B. According to the National Institute of Allergy and Infectious Diseases, 50,000 new cases of HIV infections occur annually in the U.S., and nearly 33 million people are infected with HIV in the world. Even incidence of Human papillomavirus (HPV), Chlamydia, Gonorrhea, HIV and Syphilis (primary and secondary) is in rise.
• Major players in the market include Cepheid, Beckton Dickinson, Gen Probe (Hologic), Qiagen, Roche Diagnostics, Bayer Healthcare, Dako, Abbott Laboratories, Danaher Corporation, Siemens, Sysmex Corporation, Grifols, and Biomérieux Sa.

Ameri Research has segmented the Infectious Disease Molecular Diagnostics Market by Products, Test Location, Technology, Regional Outlook.

Market Segmentation:

Infectious Disease Molecular Diagnostics Market by Disease Type (Revenue, USD Million, 2014- 2025)
• Hepatitis B
• Tuberculosis (TB)
• Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
• Human Papillomavirus (HPV)
• Human Immunodeficiency Virus (HIV)
• Hepatitis C
• Methicillin-Resistant Staphylococcus Aureus (MRSA)
• Other Infectious Diseases

Infectious Disease Molecular Diagnostics Market by Products (Revenue, USD Million, 2014 – 2025)
• Instruments
• Reagents & Kits
• Software & Services

Infectious Disease Molecular Diagnostics Market by Test Location (Revenue, USD Million, 2014- 2025)
• Clinics/Lab
• Point of Care

Infectious Disease Molecular Diagnostics Market by Technology (Revenue, USD Million, 2014- 2025)
• PCR
• In Situ Hybridization
• Chips and microarrays
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Mass spectrometry
• Sequencing
• Transcription Mediated Amplification

Infectious Disease Molecular Diagnostics Systems Regional Outlook (Revenue, USD Million, 2014- 2025)
• North America
o U.S.
o Canada

• Europe
o UK
o Germany
o France
o Italy
o Spain

• Asia Pacific
o Japan
o China
o India
o Australia

• Latin America
o Brazil
o Mexico
o Columbia

• Middle East and Africa
o South Africa
o Saudi Arabia

Browse Full Report @ www.ameriresearch.com/product/infectious-disease-molecular-diagnostics-market/

About Us:

Ameri Research Inc. (www.ameriresearch.com) is a U.S. based market research and consulting company, registered in the State of Florida and headquartered in Tampa Bay Area. At Ameri Research we are passionately curious about people, markets, brands and society. Our ability to gauge market movements, deep expertise in data science, strong domain expertise and years of collective global experiences helps us to bring unmatched quality in deliverables to our clients. With carefully planned systems and processes in place, we cater to the requirements of our clients in a timely and cost-efficient manner, bringing increased predictability to their business. Each year we are publishing more than 100 syndicated reports in healthcare, chemicals, materials, food & beverages, defense & aerospace, media & entertainment, sports & fitness, and energy. We offer our clients a unique depth of knowledge and expertise around-

Market Mapping
Opportunity Assessment
Positioning
Pricing Analysis
Market Entry Strategy
Competitive Intelligence
Program Evaluation
Performance Reporting
Data Analytics
Developing a culture of collaboration and curiosity, we attract the highest caliber of likeminded people having ability to influence and shape the future.

Follow us on LinkedIn for our latest upcoming reports www.linkedin.com/company/ameri-research-inc./
Follow us on Facebook for our latest upcoming reports www.facebook.com/AmeriResearchInc/
Follow us on Twitter for our latest upcoming reports www.twitter.com/AmeriResearch

Contact Us:
Ameri Research Inc.
6816 Muncaster Ct,
Tampa, FL 33625
United States.
Tel: 1-813-666-0858
Email: Inquiry@ameriresearch.com
Web: www.ameriresearch.com

This release was published on openPR.